You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 159 No. 22, December 13, 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug-Induced Neutropenias: Now and Then

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In a recent article by van der Klauw et al,1 it was observed that the highest risks for developing drug-induced agranulocytosis were found for thyroid inhibitors, sulfamethoxazole-trimethoprim, sulfasalazine, chlomipramine hydrochloride, and dipyrone combined with analgesics. In a less sophisticated survey of all cases of drug-induced neutropenia that were reported into the computerized patient diagnosis register in Stockholm, Sweden, more than 20 years ago, my colleague and I2 found strikingly similar results. Although the panorama of drugs that are available in the marketplace has changed so much over the years, those causing neutropenia are still very similar and still on the market. It is of interest to note that although agranulocytosis (and other blood dyscrasias) caused by sulfamethoxazole-trimethoprim is seldom fatal, it is extremely costly for society.3

Jan Palmblad, MD, PhD
Huddinge, Sweden

1. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159:369-374. FREE FULL TEXT
2. Arneborn P, Palmblad J. Drug-induced neutropenia: survey for Stockholm 1973-1978. Acta Med Scand. 1982;212:289-292. PUBMED
3. Keisu M, Wiholm BE, Palmblad J. Trimethoprim-sulfamethoxazole–associated blood dyscrasias. J Intern Med. 1990;228:353-360. WEB OF SCIENCE | PUBMED


In reply

We would like to thank Dr Palmblad for his interest in our article.1 Indeed, In their . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hyponatremia
Arieff et al.
NEJM 2000;343:886-888.
FULL TEXT  

Drug-Induced Allergic Cytopenia: In Vitro Confirmation by the Lymphocyte Transformation Test
Sachs et al.
Arch Intern Med 2000;160:2218-2219.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.